Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
Funds safer medication management using biomarkers, clinical data and decision support.
Projects should combine biomedical research with health technologies, electronic health records and decision-support systems, while addressing drug-drug, drug-gene and drug-food interactions, prescription cascades and deprescribing or dose adjustment. Proposals must generate evidence on clinical utility and cost-effectiveness, address ethical, regulatory and implementation barriers, support integr…
This Research and Innovation Action targets adverse drug reactions caused by three or more medicines taken together. Projects should use pharmacogenomics, pharmacokinetics, pharmacodynamics, biomarkers and patient stratification to predict and prevent harm, improve medication management, and support safer, more effective and personalised treatment.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up